Novartis Healthcare A/S clinical trials
A country office of Novartis
The registry lists 1 studies whose lead sponsor is Novartis Healthcare A/S. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 29, 2015.
- 1study on the registry
- 0open to participants now
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Where
- Denmark1
Over the years
- 113
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Novartis Healthcare A/S1 study
Something wrong with this grouping? Tell us on the Novartis page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Novartis studies →
- Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast CancerCompletedNCT02023359
Sponsor listed in the registry: Novartis Healthcare A/S